H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Go back to H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 107.62 +2.73 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.89 | 52 Week High | $18.39 | |||
| Open | $106.39 | 52 Week Low | $6.96 | |||
| Day High | $107.96 | P/E | N/A | |||
| Day Low | $105.50 | EPS | $-0.58 | |||
| Volume | 2,539,016 | |||||
